Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

RNA Isolation Kit

November 18, 2010 8:01 am | Product Releases | Comments

AMSBIO has announced new kits for the isolation of high quality RNA from formalin-fixed paraffin-embedded tissues and LCM samples that can be applied both to qRT-PCR and a variety of microarray platforms.


Nabi Completes NicVAX Trial Enrollment

November 18, 2010 7:56 am | News | Comments

Nabi Biopharmaceuticals has completed enrollment in the second Phase 3 clinical trial of NicVAX, the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.


Trophos Presents Data on Mitochondrial Dysfunction

November 18, 2010 7:52 am | News | Comments

Trophos SA and partners in the MitoTarget consortium presented data demonstrating the potential for treating a range of neurodegenerative diseases by targeting mitochondrial dysfunction and also focused on mechanisms involved in neuronal death.


Threshold Releases TH-302 Results

November 18, 2010 7:41 am | News | Comments

Threshold Pharmaceuticals, Inc. announced clinical trial results related to Threshold's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.



November 18, 2010 7:36 am | News | Comments

Prism Pharmaceuticals, Inc. announced that the FDA has approved the supplemental new drug application for NEXTERONE (amiodarone HCl) Premixed Injection, the first and only premixed intravenous bag formulation of the antiarrhythmic agent amiodarone IV.


Pericytes May Be Key Player in Alzheimer's

November 18, 2010 7:30 am | News | Comments

Cells in the brain called pericytes that have not been high on the list of targets for treating diseases like Alzheimer's may play a more crucial role in the development of neurodegenerative diseases than has been realized.


Scientists Locate Genetic Target for Heart Disease

November 18, 2010 7:27 am | News | Comments

Researchers at the University of Cincinnati (UC) have found a potential genetic target for heart disease, which could lead to therapies to prevent the development of the nation's No. 1 killer in its initial stages.


MS Drug May Lead Fight Against Bioterrorism

November 18, 2010 7:18 am | News | Comments

Scientists are reporting that variants of a drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin — the most poisonous substance known to man.


Researchers Find Key to Fighting Non-Adherence

November 18, 2010 7:12 am | News | Comments

Medications do not have a chance to fight health problems if they are taken improperly or not taken at all. Non-adherence to medications costs thousands of lives and billions of dollars each year in the United States alone.


Gene Therapy Wipes Out Melanoma

November 18, 2010 6:49 am | News | Comments

A potent anti-tumor gene introduced into mice with metastatic melanoma has resulted in permanent immune reconfiguration and produced a complete remission of their cancer.


45 Million Americans Suffer From Mental Illness

November 18, 2010 6:39 am | News | Comments

The government says 1 in 5 American adults suffered from mental illness during the past year. Fewer than 4 in 10 received treatment for their mental health condition.


Medicare Advisors Back Provenge Payment

November 18, 2010 6:35 am | by Matthew Perrone | News | Comments

Medicare advisers supported the effectiveness of the prostate cancer drug Provenge, an innovative therapy that has prompted questions about the cost of medical care and the government's role in paying for it.


Drug-Resistant Malaria Spreading in Asia

November 18, 2010 6:28 am | News | Comments

The World Health Organization says countries are not doing enough to detect drug-resistant malaria, which is spreading in Southeast Asia. WHO says a strain of the mosquito-borne disease resistant to the most effective antimalarial drugs emerged two years ago.


Anacetrapib Could Be Blockbuster for Merck

November 18, 2010 6:24 am | by Tom Murphy | News | Comments

A new drug being developed by Merck & Co., anacetrapib, is aimed at a significant number of patients who are not being helped by statin medicines like Pfizer's current best seller Lipitor, and eventually could net billions of dollars in annual sales for Merck.


Centrifuge Tubes

November 17, 2010 8:29 am | Product Releases | Comments

Sterilin has launched an extended range of sterile polypropylene centrifuge tubes that offers increased speed capability of up to 12,000 g. The high quality standard range is suitable for a wide range of general laboratory applications.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.